Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVIDE: Polio and Rotavirus Vaccine Efficacy in Bangladesh
NCT01375647Phase 3Completed
- Sponsor
- The University of Vermont
- Start
- May 2011
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes, Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of human rotavirus RIX4414 strain vaccine, trivalent inactivated polio vaccine in rotavirus infection, poliomyelitis, sponsored by The University of Vermont. Started May 2011; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccinetrivalent inactivated polio vaccine
03
Conditions
rotavirus infectionpoliomyelitis
Beyond the preview
Go deeper on NCT01375647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01375647.